Balentine LLC Grifols Sa Transaction History
Balentine LLC
- $2.54 Billion
- Q3 2024
Shares
4 transactions
Others Institutions Holding GRFS
# of Institutions
162Shares Held
140MCall Options Held
288KPut Options Held
389K-
Capital World Investors Los Angeles, CA21MShares$199 Million0.03% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA19.9MShares$188 Million2.11% of portfolio
-
Permian Investment Partners, LP New York, NY12.3MShares$117 Million16.06% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.1MShares$105 Million3.5% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny10.7MShares$102 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.43B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...